Saturday 17 October 2026
Export PRLB’s income statement to Excel — free account
Proto Labs, Inc.
PRLB Industrials Metal Fabrication
Proto Labs, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $533.1 million, up 6.44% from fiscal 2024. In the quarter to June 2026, revenue grew 10.6%, EPS grew 100.0% and free cash flow grew 1.35%, each against the same quarter a year earlier.
85.65
1.76
−2.01%
Follow PRLB
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
64.18 | 52.80 | 56.84 | 80.69 |
+8 more quarters Free account |
P/S ratio |
3.49 | 2.49 | 2.27 | 2.31 | |
P/FCF ratio |
33.24 | 23.17 | 20.01 | 17.44 | |
P/Operating CF |
126.52 | 77.51 | 73.57 | 41.09 | |
P/B ratio |
2.82 | 1.99 | 1.80 | 1.80 | |
Price to Tangible BV |
4.87 | 3.47 | 3.17 | 3.22 | |
EV/Sales |
3.24 | 2.25 | 2.04 | 2.09 | |
EV/EBITDA |
26.12 | 19.30 | 18.45 | 21.06 | |
EV/Operating CF |
23.13 | 16.67 | 14.59 | 14.35 | |
EV/FCF |
30.90 | 20.94 | 17.97 | 15.77 | |
Quick Ratio |
3.27 | 3.15 | 3.13 | 2.89 | |
Current Ratio |
3.64 | 3.51 | 3.49 | 3.24 | |
Net Debt/EBITDA |
(7.34) | (7.61) | (8.59) | (6.92) | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.73 | 0.72 | 0.71 | 0.69 | |
Operating CF/Net income |
1.69 | 2.16 | 2.74 | 4.03 | |
Capex/Depreciation |
(0.77) | (0.28) | (0.99) | (0.39) | |
Research and Development Expense of Revenue |
7.23% | 7.56% | 7.56% | 7.91% | |
Selling, General and Administrative Expense of Revenue |
30.35% | 29.99% | 31.00% | 30.83% | |
Intangible Assets out of Total Assets |
0.37 | 0.37 | 0.38 | 0.39 | |
Share Based Compensation of Revenue |
2.74% | 2.31% | 2.78% | 2.72% | |
Graham Net Nets |
0.09 | 0.11 | 0.12 | 0.11 | |
Graham Number |
28.72 | 26.39 | 23.75 | 19.70 | |
Earnings Yield |
1.56% | 1.89% | 1.76% | 1.24% | |
Free Cash Flow Yield |
3.01% | 4.32% | 5.00% | 5.73% | |
Revenue per Share |
6.23 | 5.85 | 5.71 | 5.67 | |
Operating CF per Share |
0.64 | 0.74 | 0.69 | 1.22 | |
Capex per Share |
(0.26) | (0.09) | (0.34) | (0.14) | |
Free Cash Flow per Share |
0.39 | 0.64 | 0.35 | 1.08 | |
Cash per Share |
5.96 | 5.72 | 5.36 | 4.99 | |
Shareholders Equity per Share |
28.86 | 28.66 | 28.17 | 27.83 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
28.86 | 28.66 | 28.17 | 27.83 | |
Free Cash Flow |
9.24 | 15.28 | 8.42 | 25.84 | |
Working Capital |
193.04 | 177.86 | 166.54 | 156.05 | |
Capital Expenditures |
(6.20) | (2.26) | (8.03) | (3.25) | |
Net Current Asset Value |
166.68 | 153.14 | 144.06 | 133.66 | |
EV/EBIT |
49.34 | 40.37 | 43.30 | 64.29 | |
Capex to Sales |
0.04 | 0.02 | 0.06 | 0.02 | |
Price to Operating Income |
53.08 | 44.68 | 48.20 | 71.08 | |
| Other line items | |||||
Average Receivables |
87.82 | 80.75 | 75.42 | 76.30 | |
Average Payables |
18.56 | 17.96 | 15.30 | 16.20 | |
Average Inventory |
14.29 | 14.04 | 13.35 | 13.24 | |
Average Assets |
767.28 | 758.01 | 753.46 | 755.32 | |
Average Common Equity |
678.22 | 669.96 | 672.04 | 672.36 |
Columns are period end dates